The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Injectable Drugs-Global Market Insights and Sales Trends 2024
Synopsis
Drug injection is a method of introducing a drug into the bloodstream via a hollow hypodermic needle and a syringe, which is pierced through the skin into the body.
The global Injectable Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Injectable Drugs in various end use industries. The expanding demands from the Hospital, Clinic, Home Care and Others, are propelling Injectable Drugs market. Ampoules, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Vials segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Packaging Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Injectable Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Injectable Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Injectable Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Injectable Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Injectable Drugs covered in this report include AbbVie, F. Hoffmann-La Roche, GlaxoSmithKline and Sanofi, etc.
The global Injectable Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AbbVie
F. Hoffmann-La Roche
GlaxoSmithKline
Sanofi
Global Injectable Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Injectable Drugs market, Segment by Packaging Type:
Ampoules
Vials
Cartridges
Bottles
Global Injectable Drugs market, by Application
Hospital
Clinic
Home Care
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Packaging Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Injectable Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Injectable Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Drug injection is a method of introducing a drug into the bloodstream via a hollow hypodermic needle and a syringe, which is pierced through the skin into the body.
The global Injectable Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Injectable Drugs in various end use industries. The expanding demands from the Hospital, Clinic, Home Care and Others, are propelling Injectable Drugs market. Ampoules, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Vials segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Packaging Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Injectable Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Injectable Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Injectable Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Injectable Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Injectable Drugs covered in this report include AbbVie, F. Hoffmann-La Roche, GlaxoSmithKline and Sanofi, etc.
The global Injectable Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AbbVie
F. Hoffmann-La Roche
GlaxoSmithKline
Sanofi
Global Injectable Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Injectable Drugs market, Segment by Packaging Type:
Ampoules
Vials
Cartridges
Bottles
Global Injectable Drugs market, by Application
Hospital
Clinic
Home Care
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Packaging Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Injectable Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Injectable Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Injectable Drugs Market Overview
1.1 Injectable Drugs Product Overview
1.2 Injectable Drugs Market Segment by Packaging Type
1.2.1 Ampoules
1.2.2 Vials
1.2.3 Cartridges
1.2.4 Bottles
1.3 Global Injectable Drugs Market Size by Packaging Type
1.3.1 Global Injectable Drugs Market Size Overview by Packaging Type (2018-2029)
1.3.2 Global Injectable Drugs Historic Market Size Review by Packaging Type (2018-2023)
1.3.3 Global Injectable Drugs Forecasted Market Size by Packaging Type (2024-2029)
1.4 Key Regions Market Size Segment by Packaging Type
1.4.1 North America Injectable Drugs Sales Breakdown by Packaging Type (2018-2023)
1.4.2 Europe Injectable Drugs Sales Breakdown by Packaging Type (2018-2023)
1.4.3 Asia-Pacific Injectable Drugs Sales Breakdown by Packaging Type (2018-2023)
1.4.4 Latin America Injectable Drugs Sales Breakdown by Packaging Type (2018-2023)
1.4.5 Middle East and Africa Injectable Drugs Sales Breakdown by Packaging Type (2018-2023)
2 Global Injectable Drugs Market Competition by Company
2.1 Global Top Players by Injectable Drugs Sales (2018-2023)
2.2 Global Top Players by Injectable Drugs Revenue (2018-2023)
2.3 Global Top Players by Injectable Drugs Price (2018-2023)
2.4 Global Top Manufacturers Injectable Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Injectable Drugs Market Competitive Situation and Trends
2.5.1 Injectable Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Injectable Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Injectable Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Injectable Drugs Market
2.8 Key Manufacturers Injectable Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Injectable Drugs Status and Outlook by Region
3.1 Global Injectable Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Injectable Drugs Historic Market Size by Region
3.2.1 Global Injectable Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Injectable Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Injectable Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Injectable Drugs Forecasted Market Size by Region
3.3.1 Global Injectable Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Injectable Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Injectable Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Injectable Drugs by Application
4.1 Injectable Drugs Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Home Care
4.1.4 Others
4.2 Global Injectable Drugs Market Size by Application
4.2.1 Global Injectable Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Injectable Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Injectable Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Injectable Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Injectable Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Injectable Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Injectable Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Injectable Drugs Sales Breakdown by Application (2018-2023)
5 North America Injectable Drugs by Country
5.1 North America Injectable Drugs Historic Market Size by Country
5.1.1 North America Injectable Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Injectable Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Injectable Drugs Sales in Value by Country (2018-2023)
5.2 North America Injectable Drugs Forecasted Market Size by Country
5.2.1 North America Injectable Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Injectable Drugs Sales in Value by Country (2024-2029)
6 Europe Injectable Drugs by Country
6.1 Europe Injectable Drugs Historic Market Size by Country
6.1.1 Europe Injectable Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Injectable Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Injectable Drugs Sales in Value by Country (2018-2023)
6.2 Europe Injectable Drugs Forecasted Market Size by Country
6.2.1 Europe Injectable Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Injectable Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Injectable Drugs by Region
7.1 Asia-Pacific Injectable Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Injectable Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Injectable Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Injectable Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Injectable Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Injectable Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Injectable Drugs Sales in Value by Region (2024-2029)
8 Latin America Injectable Drugs by Country
8.1 Latin America Injectable Drugs Historic Market Size by Country
8.1.1 Latin America Injectable Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Injectable Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Injectable Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Injectable Drugs Forecasted Market Size by Country
8.2.1 Latin America Injectable Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Injectable Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Injectable Drugs by Country
9.1 Middle East and Africa Injectable Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Injectable Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Injectable Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Injectable Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Injectable Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Injectable Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Injectable Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 AbbVie
10.1.1 AbbVie Company Information
10.1.2 AbbVie Introduction and Business Overview
10.1.3 AbbVie Injectable Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 AbbVie Injectable Drugs Products Offered
10.1.5 AbbVie Recent Development
10.2 F. Hoffmann-La Roche
10.2.1 F. Hoffmann-La Roche Company Information
10.2.2 F. Hoffmann-La Roche Introduction and Business Overview
10.2.3 F. Hoffmann-La Roche Injectable Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 F. Hoffmann-La Roche Injectable Drugs Products Offered
10.2.5 F. Hoffmann-La Roche Recent Development
10.3 GlaxoSmithKline
10.3.1 GlaxoSmithKline Company Information
10.3.2 GlaxoSmithKline Introduction and Business Overview
10.3.3 GlaxoSmithKline Injectable Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 GlaxoSmithKline Injectable Drugs Products Offered
10.3.5 GlaxoSmithKline Recent Development
10.4 Sanofi
10.4.1 Sanofi Company Information
10.4.2 Sanofi Introduction and Business Overview
10.4.3 Sanofi Injectable Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sanofi Injectable Drugs Products Offered
10.4.5 Sanofi Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Injectable Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Injectable Drugs Industrial Chain Analysis
11.4 Injectable Drugs Market Dynamics
11.4.1 Injectable Drugs Industry Trends
11.4.2 Injectable Drugs Market Drivers
11.4.3 Injectable Drugs Market Challenges
11.4.4 Injectable Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Injectable Drugs Distributors
12.3 Injectable Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
